Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to Rituximab
International Archives of Allergy and Immunology, 06/22/2012
Clinical Article
Vultaggio A et al. – The results show the presence of rituximab (RTX)–specific Th2–type cells and IgE antibodies, thus suggesting that type I hypersensitivity may be an additional mechanism to CRS in the development of RTX reactions.



